Armata Pharmaceuticals Announces New Financing and Leadership Transition to Accelerate Novel Bacteriophage Therapeutics - Bloomberg

Skip to content Skip to content Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support

For Customers

Support

Americas +1 212 318 2000

EMEA +44 20 7330 7500

Asia Pacific +65 6212 1000

  • Company

    Communications

    Follow

  • Products

    Industry Products

  • Media

    Media Services

  • ";var sm="
  • Company

    Communications

    Follow

  • Products

    Industry Products

  • Media

    Media Services

  • Bloomberg

    Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world

    For Customers

    Support

    Americas +1 212 318 2000

    EMEA +44 20 7330 7500

    Asia Pacific +65 6212 1000

  • ";function fillTophat(){document.querySelector(".bb-that__sitemap-sections.bb-that--visible-md").innerHTML=md;document.querySelector(".bb-that__sitemap-sections.bb-that--visible-sm").innerHTML=sm;}document.querySelector(".bb-that-header--sitemap-trigger").addEventListener("keydown",function(){fillTophat();});document.querySelector(".bb-that-header--sitemap-trigger").addEventListener("click",function(){fillTophat();});})(); Switch Editions Sign In Subscribe Business

    July 11, 2023, 12:00 PM UTC

    LIVE ON BLOOMBERG

    Watch Live TVListen to Live Radio
    https://www.bloomberg.com/amp/press-releases/2023-07-11/armata-pharmaceuticals-announces-new-financing-and-leadership-transition-to-accelerate-novel-bacteriophage-therapeutics